“Eye bags” are a description, not a diagnosis. Fullness or shadow beneath the eyes may come from prominent orbital fat, a deep tear trough, loss of cheek support, malar edema, festoons, pigmentation, visible vessels or previous filler. Removing fat without identifying the cause can leave the concern unchanged—or create a hollow, operated appearance.
Six common causes of an under-eye bag appearance
| Finding | Typical clue | Why it matters |
|---|---|---|
| Prominent orbital fat | Localized bulges within the lower eyelid | May be treated selectively during lower blepharoplasty |
| Tear-trough hollowing | A depression that creates shadow | Removing fat may deepen the hollow |
| Midface descent | Longer lid-cheek transition and lower cheek position | May require evaluation of tissue position, not just volume |
| Malar edema or festoons | Swelling over the cheek, often variable | Blepharoplasty is not a universal solution |
| Skin and pigment changes | Crepey texture, brown pigment or visible vessels | Skin-directed treatment may be more relevant |
| Previous filler | Persistent fullness, irregularity or edema | History and imaging may change the plan |
How Dr. June evaluates the lower eyelid
The examination includes ocular symptoms, eyelid tone, canthal support, fat compartments, skin, the tear trough, cheek position and facial asymmetry. Dry eye, thyroid eye disease, previous eyelid surgery and difficulty closing the eyes may require ophthalmologic assessment or a more limited operation.
Within Dr. June Favarin’s Hybrid Blepharoplasty approach, tissue is preserved whenever possible. When lower-eyelid fat requires treatment, a transconjunctival bi-incisional approach may be used to access the three compartments selectively. The goal is not to empty the orbit.
When microfat, nanofat or midface surgery may be considered
Microfat may restore carefully selected structural hollows. Nanofat is used superficially for selected skin-quality indications and does not provide a lift or meaningful projection. Video-assisted midface surgery may be considered when tissue descent—not only volume loss—contributes to the lid-cheek transition.
None of these components is automatic. A smaller operation, staged treatment or no surgery may be the more appropriate recommendation.
Previous injectables and dermatologic ultrasound
Patients should disclose hyaluronic-acid fillers, biostimulators, threads, PMMA, silicone and energy-based treatments, even when performed years earlier. Dermatologic ultrasound may help identify residual material, edema or fibrosis. Hyaluronidase works on hyaluronic acid only and cannot be expected to correct every under-eye problem.
Risks and recovery
Lower blepharoplasty risks include bleeding, infection, prolonged edema, chemosis, dry eye, asymmetry, difficulty closing the eyes, eyelid malposition, sensory change and revision surgery. Sudden visual change, severe pain or rapidly increasing one-sided swelling requires urgent assessment.
Swelling commonly becomes more visible during the first 48–72 hours. Social recovery may take one to two weeks, while residual edema and tissue settling continue longer—especially when the brow or midface is also treated.
Planning surgery from abroad
International patients begin with remote screening and complete the diagnosis in person. Surgery is performed at Hospital São José. The Belvivere Concierge assists with practical arrangements, while postoperative reviews and fitness to fly remain medical decisions.
Read more about Hybrid Blepharoplasty and malar edema and festoons.
This article is educational and does not replace an individualized medical evaluation.
